Posts
February 27 2024
Aclarion, Inc., a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced the pricing of its public offering in the amount of $3,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in the offering.
February 26 2024
Jaclyn Ruocco, a member of the Firm, wrote an article for Total Food Service titled: “New Federal and NY State Rules Remind Businesses That Worker Misclassification Can Backfire.”
Click here to read the article.
February 24 2024
MAIA Biotechnology, Inc. announced the commencement of its At The Market Offering in the amount of $1,445,000. EG&S acted as counsel to the Sales Agent.
February 24 2024
Cingulate Inc. announced the closing of its Public Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.
February 22 2024
Aclarion Inc. announced the closing of its Public Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
February 21 2024
Peraso Inc. announced the closing of its Underwritten Public Offering in the amount of $4,000,000. EG&S acted as counsel to the Underwriter.
February 21 2024
Cingulate Inc. announced the closing of its Public Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.
February 20 2024
Peraso Inc. announced the closing of its Underwritten Public Offering in the amount of $4,000,000. EG&S acted as counsel to the Underwriter.